142 related articles for article (PubMed ID: 2845643)
41. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings.
Ishigami K; Yoshimitsu K; Nishihara Y; Irie H; Asayama Y; Tajima T; Nishie A; Hirakawa M; Ushijima Y; Okamoto D; Taketomi A; Honda H
Radiology; 2009 Feb; 250(2):435-43. PubMed ID: 19095782
[TBL] [Abstract][Full Text] [Related]
42. Fine-needle aspiration cytology to distinguish dysplasia from hepatocellular carcinoma with different grades.
Lin CC; Lin CJ; Hsu CW; Chen YC; Chen WT; Lin SM
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e146-52. PubMed ID: 17532784
[TBL] [Abstract][Full Text] [Related]
43. 2-D index as a measure for estimating the complexity degree of 3-D sinusoidal structures in the normal and cirrhotic liver and in hepatocellular carcinoma.
Shimizu H; Suda K
Anal Quant Cytol Histol; 1998 Dec; 20(6):526-8. PubMed ID: 9870106
[TBL] [Abstract][Full Text] [Related]
44. Cytometric measurement of cell proliferation in echo-guided biopsies from focal lesions of the liver.
Faccioli S; Chieco P; Gramantieri L; Stecca BA; Bolondi L
Mod Pathol; 1996 Feb; 9(2):120-5. PubMed ID: 8657717
[TBL] [Abstract][Full Text] [Related]
45. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants.
Le Bail B; Bernard PH; Carles J; Balabaud C; Bioulac-Sage P
J Hepatol; 1997 Nov; 27(5):835-42. PubMed ID: 9382971
[TBL] [Abstract][Full Text] [Related]
47. Morphologic studies of the liver cell dysplasia.
Watanabe S; Okita K; Harada T; Kodama T; Numa Y; Takemoto T; Takahashi T
Cancer; 1983 Jun; 51(12):2197-205. PubMed ID: 6303546
[TBL] [Abstract][Full Text] [Related]
48. Hepatocellular carcinoma in the noncirrhotic liver.
Gaddikeri S; McNeeley MF; Wang CL; Bhargava P; Dighe MK; Yeh MM; Dubinsky TJ; Kolokythas O; Lalwani N
AJR Am J Roentgenol; 2014 Jul; 203(1):W34-47. PubMed ID: 24951228
[TBL] [Abstract][Full Text] [Related]
49. Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers.
Liu X; Wang SK; Zhang K; Zhang H; Pan Q; Liu Z; Pan H; Xue L; Yen Y; Chu PG
Carcinogenesis; 2015 Feb; 36(2):232-42. PubMed ID: 25542894
[TBL] [Abstract][Full Text] [Related]
50. Quantitative nuclear-cytoplasmic ratios in human hepatomas.
Gallagher JC
Arch Pathol Lab Med; 1978 Apr; 102(4):189-92. PubMed ID: 207235
[TBL] [Abstract][Full Text] [Related]
51. Difference in the three-dimensional structure of the sinusoids between hepatocellular carcinoma and cirrhotic liver.
Shimizu H; Suda K; Yokoyama T
Pathol Int; 1996 Dec; 46(12):992-6. PubMed ID: 9110352
[TBL] [Abstract][Full Text] [Related]
52. Digital quantitation of HCC-associated stem cell markers and protein quality control factors using tissue arrays of human liver sections.
Buzzanco A; Gomez A; Rodriguez E; French BA; Tillman BA; Chang S; Ganapathy E; Junrungsee S; Zarrinpar A; Agopian VG; Naini BV; French SW; French SW
Exp Mol Pathol; 2014 Dec; 97(3):399-410. PubMed ID: 25218810
[TBL] [Abstract][Full Text] [Related]
53. β-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study.
Ando S; Shibahara J; Hayashi A; Fukayama M
Virchows Arch; 2015 Nov; 467(5):535-42. PubMed ID: 26311355
[TBL] [Abstract][Full Text] [Related]
54. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
[TBL] [Abstract][Full Text] [Related]
55. Morphometric study of hepatocytes containing hepatitis B surface antigen.
Chen ML; Gerber MA; Thung SN; Thornton JC; Chung WK
Am J Pathol; 1984 Feb; 114(2):217-21. PubMed ID: 6320648
[TBL] [Abstract][Full Text] [Related]
56. [Clinicopathological significance of adenomatous hyperplasia of the liver].
Nakashima O; Kojiro M
Nihon Rinsho; 1994 Jan; 52(1):75-9. PubMed ID: 8114314
[TBL] [Abstract][Full Text] [Related]
57. Evidence for heightened hexokinase II immunoexpression in hepatocyte dysplasia and hepatocellular carcinoma.
Guzman G; Chennuri R; Chan A; Rea B; Quintana A; Patel R; Xu PZ; Xie H; Hay N
Dig Dis Sci; 2015 Feb; 60(2):420-6. PubMed ID: 25381201
[TBL] [Abstract][Full Text] [Related]
58. Histopathologic features of hepatocellular carcinoma in Zaire.
Kashala LO; Conne B; Kalengayi MM; Kapanci Y; Frei PC; Lambert PH
Cancer; 1990 Jan; 65(1):130-4. PubMed ID: 2152849
[TBL] [Abstract][Full Text] [Related]
59. Apoptosis and proliferation in hepatocarcinogenesis related to cirrhosis.
Park YN; Chae KJ; Kim YB; Park C; Theise N
Cancer; 2001 Dec; 92(11):2733-8. PubMed ID: 11753945
[TBL] [Abstract][Full Text] [Related]
60. Nucleolar organizer regions in cirrhosis and hepatocellular carcinoma.
Jain R; Malhotra V; Kumar N; Sarin SK
Trop Gastroenterol; 1998; 19(3):100-1. PubMed ID: 9828706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
